A Phase 2 Study of Three Low-Dose Intensity Subcutaneous Bortezomib Regimens in Elderly Frail Patients with Untreated Multiple Myeloma
Leukemia(2016)
Key words
Combination drug therapy,Geriatrics,Medical research,Myeloma,Phase II trials,Medicine/Public Health,general,Internal Medicine,Intensive / Critical Care Medicine,Cancer Research,Oncology,Hematology
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined